A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells
Open Access
- 22 May 2003
- journal article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 10 (6), 729-739
- https://doi.org/10.1038/sj.cdd.4401232
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Enzymes of Sphingolipid Metabolism: From Modular to Integrative SignalingBiochemistry, 2001
- Natural Ceramide Reverses Fas Resistance of Acid Sphingomyelinase −− HepatocytesJournal of Biological Chemistry, 2001
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- TRAIL/Apo-2-ligand-induced apoptosis in human T cellsEuropean Journal of Immunology, 1998
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.Journal of Clinical Investigation, 1996
- Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmACurrent Biology, 1996
- FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling ComplexCell, 1996
- Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell DeathCell, 1996
- A possible role of sphingosine in induction of apoptosis by tumor necrosis factor‐α, in human neutrophilsFEBS Letters, 1994